16th World Clinical Biomarkers & CDx Summit
It is time to get the band together and lock in your complimentary* passes to the 16th World Clinical Biomarkers & Companion Diagnostics Summit.
Taking place this fall, October 5-8, this forum is the prime platform to benchmark Rx-Dx strategies, uncover emerging IVD innovations, and build the global partnerships needed to deliver precision medicine at scale.
Convening 850+ senior stakeholders from biopharma, diagnostics, regulatory, healthcare, testing labs, and multimodal organizations, this forum remains the touchpoint for those looking to inform the next step in progressing drug-diagnostic programs from bench-to-bedside.
See the complete event program with sessions spanning biomarker discovery, diagnostic imaging, genomics, multi-omics, and AI-driven innovation.
To reflect how the field is moving today, we have reworked the agenda to include brand-new data-driven case studies, additional networking, enhanced stakeholder perspectives and five tracks of content.
For the first time, gain insights from:
- AI & Tech Innovators: Hear how AWS, Google Cloud and Microsoft are innovating cutting-edge AI and advanced compute to harness omics, digital imaging, and multimodal data to deliver compliant, scalable, insight-ready intelligence.
- Precision Oncology Associations & Charities: Learn how BLOODPAC, Precision Cancer Consortium and TargetCancer Foundation are accelerating calls-to-arms in testing, R&D innovation, standardization, and equitable access, ensuring harmonized approvals, launches and adoption of drug-diagnostics.
- Non-Oncology Biopharma Pioneers: Discover how novel biomarkers and advances in non-invasive multimodal IVD assays are elevating the standards of care and enabling earlier detection with Alexion Pharmaceuticals, Novartis and PTC Therapeutics.
With registration now open to claim your free* biopharma pass, join the wave of experts enabling biomarker discovery, CDx development, regulatory success, reimbursement readiness and scalable access for patients across oncology, autoimmune, neurological, chronic and rare diseases.
Save your place here alongside teams at Acrivon Therapeutics, AstraZeneca, Bristol Myers Squibb, Johnson & Johnson Innovative Medicines, Novartis, Takeda and more!
Attendance is FREE* for qualifying biopharma and researchers.
*Subject to terms and conditions: Visit the website to learn more.
